These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 38702933)

  • 21. C-terminal α-synuclein truncations are linked to cysteine cathepsin activity in Parkinson's disease.
    McGlinchey RP; Lacy SM; Huffer KE; Tayebi N; Sidransky E; Lee JC
    J Biol Chem; 2019 Jun; 294(25):9973-9984. PubMed ID: 31092553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration.
    Duffy MF; Collier TJ; Patterson JR; Kemp CJ; Luk KC; Tansey MG; Paumier KL; Kanaan NM; Fischer DL; Polinski NK; Barth OL; Howe JW; Vaikath NN; Majbour NK; El-Agnaf OMA; Sortwell CE
    J Neuroinflammation; 2018 May; 15(1):129. PubMed ID: 29716614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nitrated alpha-synuclein-activated microglial profiling for Parkinson's disease.
    Reynolds AD; Glanzer JG; Kadiu I; Ricardo-Dukelow M; Chaudhuri A; Ciborowski P; Cerny R; Gelman B; Thomas MP; Mosley RL; Gendelman HE
    J Neurochem; 2008 Mar; 104(6):1504-25. PubMed ID: 18036154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-let-7a suppresses α-Synuclein-induced microglia inflammation through targeting STAT3 in Parkinson's disease.
    Zhang J; Dongwei Zhou ; Zhang Z; Xinhui Qu ; Kunwang Bao ; Guohui Lu ; Jian Duan
    Biochem Biophys Res Commun; 2019 Nov; 519(4):740-746. PubMed ID: 31547989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TLR4 deficiency has a protective effect in the MPTP/probenecid mouse model of Parkinson's disease.
    Shao QH; Chen Y; Li FF; Wang S; Zhang XL; Yuan YH; Chen NH
    Acta Pharmacol Sin; 2019 Dec; 40(12):1503-1512. PubMed ID: 31388087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Secretome of bone marrow mesenchymal stromal cells cultured in a dynamic system induces neuroprotection and modulates microglial responsiveness in an α-synuclein overexpression rat model.
    Marques CR; Campos J; Sampaio-Marques B; Antunes FF; Dos Santos Cunha RM; Silva D; Barata-Antunes S; Lima R; Fernandes-Platzgummer A; da Silva CL; Sousa RA; Salgado AJ
    Cytotherapy; 2024 Jul; 26(7):700-713. PubMed ID: 38483360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of IL-6R Expression on IL-6/STAT3/HIF-1α Signaling Pathway in a Mouse Model of Parkinson's Disease with Type 2 Diabetes Co-Morbidity.
    Hu A; She Y; Wang Y; Cao X; Li R; Wang J; Yu L; Jiang H; Zhao Y
    Discov Med; 2024 Jul; 36(186):1386-1397. PubMed ID: 39054710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exosomes of BV-2 cells induced by alpha-synuclein: important mediator of neurodegeneration in PD.
    Chang C; Lang H; Geng N; Wang J; Li N; Wang X
    Neurosci Lett; 2013 Aug; 548():190-5. PubMed ID: 23792198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons.
    Mazzulli JR; Zunke F; Tsunemi T; Toker NJ; Jeon S; Burbulla LF; Patnaik S; Sidransky E; Marugan JJ; Sue CM; Krainc D
    J Neurosci; 2016 Jul; 36(29):7693-706. PubMed ID: 27445146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association Between Decreased Srpk3 Expression and Increased Substantia Nigra Alpha-Synuclein Level in an MPTP-Induced Parkinson's Disease Mouse Model.
    Seo MH; Yeo S
    Mol Neurobiol; 2023 Feb; 60(2):780-788. PubMed ID: 36369636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exosome-mediated delivery of antisense oligonucleotides targeting α-synuclein ameliorates the pathology in a mouse model of Parkinson's disease.
    Yang J; Luo S; Zhang J; Yu T; Fu Z; Zheng Y; Xu X; Liu C; Fan M; Zhang Z
    Neurobiol Dis; 2021 Jan; 148():105218. PubMed ID: 33296726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease.
    Chen J; Mao K; Yu H; Wen Y; She H; Zhang H; Liu L; Li M; Li W; Zou F
    J Neuroinflammation; 2021 Dec; 18(1):295. PubMed ID: 34930303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of α-synuclein in microglia: autophagy and phagocytosis balance neuroinflammation in Parkinson's disease.
    Lv QK; Tao KX; Wang XB; Yao XY; Pang MZ; Liu JY; Wang F; Liu CF
    Inflamm Res; 2023 Mar; 72(3):443-462. PubMed ID: 36598534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The gamma chain subunit of Fc receptors is required for alpha-synuclein-induced pro-inflammatory signaling in microglia.
    Cao S; Standaert DG; Harms AS
    J Neuroinflammation; 2012 Nov; 9():259. PubMed ID: 23186369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The vicious cycle between α-synuclein aggregation and autophagic-lysosomal dysfunction.
    Bellomo G; Paciotti S; Gatticchi L; Parnetti L
    Mov Disord; 2020 Jan; 35(1):34-44. PubMed ID: 31729779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NLRP3 Inflammasome Inhibition Prevents α-Synuclein Pathology by Relieving Autophagy Dysfunction in Chronic MPTP-Treated NLRP3 Knockout Mice.
    Ou Z; Zhou Y; Wang L; Xue L; Zheng J; Chen L; Tong Q
    Mol Neurobiol; 2021 Apr; 58(4):1303-1311. PubMed ID: 33169332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fecal Microbiota Transplantation Exerts a Protective Role in MPTP-Induced Parkinson's Disease via the TLR4/PI3K/AKT/NF-κB Pathway Stimulated by α-Synuclein.
    Zhong Z; Chen W; Gao H; Che N; Xu M; Yang L; Zhang Y; Ye M
    Neurochem Res; 2021 Nov; 46(11):3050-3058. PubMed ID: 34347266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroprotective effects of Astilbin on MPTP-induced Parkinson's disease mice: Glial reaction, α-synuclein expression and oxidative stress.
    Zhu YL; Sun MF; Jia XB; Cheng K; Xu YD; Zhou ZL; Zhang PH; Qiao CM; Cui C; Chen X; Yang XS; Shen YQ
    Int Immunopharmacol; 2019 Jan; 66():19-27. PubMed ID: 30419450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cx3cr1-deficiency exacerbates alpha-synuclein-A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease.
    Castro-Sánchez S; García-Yagüe ÁJ; López-Royo T; Casarejos M; Lanciego JL; Lastres-Becker I
    Glia; 2018 Aug; 66(8):1752-1762. PubMed ID: 29624735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoamine Oxidase-B Inhibition Facilitates α-Synuclein Secretion
    Nakamura Y; Arawaka S; Sato H; Sasaki A; Shigekiyo T; Takahata K; Tsunekawa H; Kato T
    J Neurosci; 2021 Sep; 41(35):7479-7491. PubMed ID: 34290084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.